News for 'DCGI'

How India narrowly escaped a health crisis

How India narrowly escaped a health crisis

Rediff.com5 Dec 2017

The Philippines launches probe after Sanofi reveals WHO-approved dengvaxia - a dengue vaccine - aggravates symptoms in some cases.

Are the COVID-19 figures in India correct?

Are the COVID-19 figures in India correct?

Rediff.com21 Apr 2020

'In our country, there is a lot of checks and balances, the figures cannot go wrong.' 'Because they are being checked by not only the governments, but by doctors themselves.'

Record spike in deaths as India COVID-19 tally tops 4.25 lakh

Record spike in deaths as India COVID-19 tally tops 4.25 lakh

Rediff.com23 Jun 2020

As the death toll in the country from coronavirus jumped by a record 445 to 13,699, the Centre maintained that the number of infections per lakh population was among the lowest in the world. The new cases surged by over 10,000 for the 11th day in a row and rose by 14,821 to take the total to 4,25,282, according to health ministry data.

MNC pharma cos may be afflicted by pneumonia virus

MNC pharma cos may be afflicted by pneumonia virus

Rediff.com22 Apr 2019

Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.

Indian drug regulator threatens to ban Ranbaxy

Indian drug regulator threatens to ban Ranbaxy

Rediff.com29 Jan 2014

A day after getting a show-cause notice from the Indian regulator, senior executives from Ranbaxy Laboratories approached the drug controller's office on Tuesday afternoon, it was learnt.

Faulty hip implants: Centre to ask J&J to compensate victims

Faulty hip implants: Centre to ask J&J to compensate victims

Rediff.com30 Aug 2018

Once the patients are identified, the government will decide on the quantum of compensation in each case and then approach J&J for claim settlement.

Sensex soars 237 points ahead of Brexit poll outcome

Sensex soars 237 points ahead of Brexit poll outcome

Rediff.com23 Jun 2016

Participants will watch out for the Brexit poll outcome in the late morning trades tomorrow.

Keep us in loop before any FDA swoop, India tells US

Keep us in loop before any FDA swoop, India tells US

Rediff.com11 Feb 2014

Inspections only in domestic authorities' presence, visiting US drug regulator told

How safe are cheap medicines made in India?

How safe are cheap medicines made in India?

Rediff.com11 Mar 2016

An International Policy Network report in 2010 found that seven per cent of drugs bought from wholesale traders were substandard, and 3.6 per cent of the drugs from traders contained no active ingredient whatsoever.

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.

« Prev  |